TAG-72 Antibodies

Santa Cruz Biotechnology features a diverse variety of TAG-72 monoclonal antibodies for various research applications. TAG-72 monoclonal antibodies excel in techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAG-72, a tumor-associated glycoprotein, plays a significant role in cancer biology, particularly in gastrointestinal tumors. TAG-72 expression is often associated with tumor progression and metastasis, making it a key biomarker for diagnostic and therapeutic purposes. The detection and quantification of TAG-72 can provide valuable insights into tumor behavior and patient prognosis. Researchers can utilize TAG-72 monoclonal antibodies to explore molecular mechanisms underlying cancer development and progression. Understanding TAG-72's role in different cancer types helps advance therapeutic strategies and biomarker development. TAG-72 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to cancer research and improve patient outcomes.